Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target.
Kushibiki T, Nakamura T, Tsuda M, Tsuchikawa T, Hontani K, Inoko K, Takahashi M, Asano T, Okamura K, Murakami S, Kurashima Y, Ebihara Y, Noji T, Nakanishi Y, Tanaka K, Maishi N, Sasaki K, Park WR, Shichinohe T, Hida K, Tanaka S, Hirano S. Kushibiki T, et al. Mol Cancer Ther. 2020 Jan;19(1):187-198. doi: 10.1158/1535-7163.MCT-19-0491. Epub 2019 Oct 9. Mol Cancer Ther. 2020. PMID: 31597713 Free article.
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer.
Inoko K, Hiraoka K, Inagaki A, Takahashi M, Kushibiki T, Hontani K, Takano H, Sato S, Takeuchi S, Nakamura T, Tsuchikawa T, Shichinohe T, Gruber HE, Jolly DJ, Kasahara N, Hirano S. Inoko K, et al. Among authors: kushibiki t. Cancer Gene Ther. 2018 Aug;25(7-8):184-195. doi: 10.1038/s41417-018-0020-7. Epub 2018 May 8. Cancer Gene Ther. 2018. PMID: 29735994 Free article.
Application of Optogenetics in Gene Therapy.
Kushibiki T, Ishihara M. Kushibiki T, et al. Curr Gene Ther. 2018;18(1):40-44. doi: 10.2174/1566523218666180302163814. Curr Gene Ther. 2018. PMID: 29512463 Review.
Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation.
Sato S, Nakamura T, Katagiri T, Tsuchikawa T, Kushibiki T, Hontani K, Takahashi M, Inoko K, Takano H, Abe H, Takeuchi S, Ono M, Kuwabara S, Umemoto K, Suzuki T, Sato O, Nakamura Y, Hirano S. Sato S, et al. Among authors: kushibiki t. Oncotarget. 2017 Oct 19;8(69):113662-113672. doi: 10.18632/oncotarget.21939. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371937 Free PMC article.
Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors.
Hontani K, Tsuchikawa T, Hiwasa T, Nakamura T, Ueno T, Kushibiki T, Takahashi M, Inoko K, Takano H, Takeuchi S, Dosaka-Akita H, Kuwatani M, Sakamoto N, Hatanaka Y, Mitsuhashi T, Shimada H, Shichinohe T, Hirano S. Hontani K, et al. Among authors: kushibiki t. Oncotarget. 2017 Oct 31;8(63):106206-106221. doi: 10.18632/oncotarget.22175. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29290942 Free PMC article.
65 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page